Secosteroids

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

Retrieved on: 
Monday, May 24, 2021
Bad Homburg vor der Höhe, Secosteroids, Vitamin D, Vifor Pharma, Companies, OPKO Health, Fresenius, Germany, Calcifediol, Calcitriol, Secondary hyperparathyroidism, Health care

MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).

Key Points: 
  • MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).
  • RAYALDEE is an extended release formulation of calcifediol, a prohormone of calcitriol, the active form of vitamin D3.
  • RAYALDEE is approved to treat SHPT in adults with stage 3 or 4 CKD and vitamin D insufficiency in the U.S. and 11 European countries.
  • Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care) is part of the Vifor Pharma Group (VPG), a global pharmaceutical company.

Enzymedica Launches Innovative New Vegan Vitamin D3 + K2 Made with USA Grown Shiitake Mushrooms to Help Support Immune, Bone and Digestive Health*

Retrieved on: 
Monday, February 8, 2021
Articles, Fungi, Branches of biology, Edible fungi, Sun tanning, Biomolecules, Secosteroids, Vitamin D, Veganism, Cholecalciferol, Vitamin, Mushroom

Enzymedica , a Florida-based company that produces high quality natural products, announced today the release of its newest immunity support supplement Vegan Vitamin D3 + K2 .

Key Points: 
  • Enzymedica , a Florida-based company that produces high quality natural products, announced today the release of its newest immunity support supplement Vegan Vitamin D3 + K2 .
  • *
    The naturally derived D3 that is included in Enzymedica's innovative new supplement is sourced entirely from USA-grown shiitake mushrooms.
  • When exposed to sunshine, shiitake mushrooms naturally produce vitamin D3 and provides a vegan, whole food source alternative to traditional D3 supplements, which typically use lanolin from sheep's wool.
  • Vitamin D, commonly known as "the sunshine vitamin", is well-known to support both innate and adaptive immune system functions.

Global Vitamin D Market Outlook and Forecast 2021-2026: Onset of the COVID-19 Pandemic has Accelerated Market Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, February 8, 2021
Retail, Other Consumer, Health, Consumer, Other Retail, Pharmaceutical, Nutrients, Vitamins, Health, Biomolecules, Nutrition, Sun tanning, Secosteroids, Vitamin D

The "Vitamin D Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vitamin D Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The industry is highly characterized by the growing demand for immune health supplements and functional foods, where the onset of the COVID-19 pandemic has further accelerated the global vitamin D market growth.
  • The global vitamin D market research report includes a detailed segmentation by analog, form, application, geography.
  • What is the growth of the vitamin D market share in India during the forecast period?

Vitamin D Liquid Liposomal Supplement Becomes Amazon's Choice Product

Retrieved on: 
Thursday, February 4, 2021
Nutrients, Organic compounds, Chemical compounds, Vitamers, Biomolecules, Sun tanning, Secosteroids, Vitamin D, Vitamin, Cholecalciferol

BELLEVUE, Wash., Feb. 4, 2021 /PRNewswire/ --2by4, manufacturer of doctor-formulated liposomal supplements, is proud to announce that its liquid vitamin D supplement has been recognized as an Amazon's Choice product.

Key Points: 
  • BELLEVUE, Wash., Feb. 4, 2021 /PRNewswire/ --2by4, manufacturer of doctor-formulated liposomal supplements, is proud to announce that its liquid vitamin D supplement has been recognized as an Amazon's Choice product.
  • 2by4 informs that its vitamin D liquid supplement is safe for adults, as well as for children.
  • It also advises that liquid form is the best way to provide vitamin D3 to children.
  • The vitamin D supplement has been manufactured in a GMP-compliant and FDA-registered facility.

Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COVID-19’s Second Wave

Retrieved on: 
Friday, November 20, 2020
Kidney diseases, Organ failure, Calcifediol, Secosteroids, Vitamin D, Fiduciary, Chronic kidney disease, Branches of biology

As a substantial investor in OPKO, we believe the Board has not only a fiduciary duty, but a humanitarian duty to distribute Rayaldee to those in need.

Key Points: 
  • As a substantial investor in OPKO, we believe the Board has not only a fiduciary duty, but a humanitarian duty to distribute Rayaldee to those in need.
  • There is no reason that so many Americans should continue dying without having the opportunity to access potential curative drugs.
  • In this letter, we outline how Rayaldee could save countless lives while also unlocking tremendous revenues for OPKO right away.
  • Calcifediol is the active ingredient in OPKOs homegrown drug Rayaldee, which is typically used to treat Chronic Kidney Disease.

Vitamin D Market Size is Projected to Reach USD 141.6 Million by 2026 - Valuates Reports

Retrieved on: 
Monday, August 31, 2020
Nutrients, Nutrition, Health, RTT, Polyenes, Secosteroids, Vitamers, Vitamin D, Vitamin, Ergocalciferol, Cholecalciferol, Rickets

Two vitamin D types are commonly used, namely, vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol).

Key Points: 
  • Two vitamin D types are commonly used, namely, vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol).
  • The vitamin D market report is segmented by area, country, firm, brand, application, and sales channel.
  • Get Detailed Analysis of COVID-19 Impact on Vitamin D Market: https://reports.valuates.com/request/sample/QYRE-Auto-4352/Global_Vitami...
    Rising incidence of diseases induced by vitamin D deficiency is expected to drive the growth of vitamin D market size during the forecast period.
  • Based on Region, Asia Pacific held the largest vitamin D market share in 2015, with China dominating the majority vitamin D market share with 86.10%.

Earthlight® Whole Food Vitamin D Receives Food Additive Petition Approval for the U.S. Market

Retrieved on: 
Tuesday, July 14, 2020
Branches of biology, Nutrients, Articles, Biomolecules, Nutrition, Secosteroids, Sun tanning, Vitamin D, Food science, Vitamin, Food additive

MORRISTOWN, N.J., July 14, 2020 /PRNewswire/ -- PLT Health Solutions, Inc. announced that Earthlight Whole Food Vitamin D has received approval of its Food Additive Petition from the U.S. Food & Drug Administration, paving the way for this unique dietary ingredient to be used in food and beverages produced and sold in the United States.

Key Points: 
  • MORRISTOWN, N.J., July 14, 2020 /PRNewswire/ -- PLT Health Solutions, Inc. announced that Earthlight Whole Food Vitamin D has received approval of its Food Additive Petition from the U.S. Food & Drug Administration, paving the way for this unique dietary ingredient to be used in food and beverages produced and sold in the United States.
  • According to Devin Stagg, Chief Operating Officer at PLT Health Solutions, FDA approval of Earthlight is timely considering rapidly growing interest in Vitamin D supplementation.
  • Adequate levels of Vitamin D have always been important, but today, people are more tuned into D than ever.
  • Earthlight is approved for use in many food & beverage products that have traditionally featured Vitamin D fortification, like breakfast cereals and meal replacements.

Vitamin D Market Worth $1.6 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, June 29, 2020
Nutrition, Nutrients, Branches of biology, Biomolecules, Vitamin deficiencies, Secosteroids, Sun tanning, Vitamin D, Vitamin, Food fortification, Vitamin D deficiency, Vitamin K

The vitamin D market has been growing in accordance with the rise in demand and consumption of feed around the world.

Key Points: 
  • The vitamin D market has been growing in accordance with the rise in demand and consumption of feed around the world.
  • Food fortification is one of the major trends, which is fueling the vitamin D market in the functional food & beverage industry.
  • Among the analogs in the vitamin D market, vitamin D3 was the dominant analog.
  • The prevalence of vitamin D deficiencies in several countries is one of the major factors fueling the growth of vitamin D market.

Vitamin D Market Worth $1.6 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, June 29, 2020
Nutrition, Nutrients, Branches of biology, Biomolecules, Vitamin deficiencies, Secosteroids, Sun tanning, Vitamin D, Vitamin, Food fortification, Vitamin D deficiency, Vitamin K

The vitamin D market has been growing in accordance with the rise in demand and consumption of feed around the world.

Key Points: 
  • The vitamin D market has been growing in accordance with the rise in demand and consumption of feed around the world.
  • Food fortification is one of the major trends, which is fueling the vitamin D market in the functional food & beverage industry.
  • Among the analogs in the vitamin D market, vitamin D3 was the dominant analog.
  • The prevalence of vitamin D deficiencies in several countries is one of the major factors fueling the growth of vitamin D market.

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients

Retrieved on: 
Monday, June 1, 2020
Secosteroids, Vitamin D, Chemical compounds, RTT, Organic compounds, Health, OPKO Health, Cholecalciferol, Calcifediol, Placebo, Calcitriol

MIAMI, June 01, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has authorized OPKO to undertake a Phase 2 trial with RAYALDEE as a treatment for patients with mild-to-moderate COVID-19.

Key Points: 
  • MIAMI, June 01, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has authorized OPKO to undertake a Phase 2 trial with RAYALDEE as a treatment for patients with mild-to-moderate COVID-19.
  • The REsCue trial will have 4 weeks of treatment with RAYALDEE or placebo and 2 weeks of follow-up.
  • COVID-19 disproportionately afflicts patients with obesity, older age, darker skin or CKD, all of which are risk factors for reduced serum 25D.
  • RAYALDEE is an extended-release oral formulation of calcifediol, a prohormone of calcitriol, the active form of vitamin D3.